Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)

INR 96.94

(4.99%)

Market Cap (In INR)

4.04 Billion

Revenue (In INR)

745.72 Million

Net Income (In INR)

185.37 Million

Avg. Volume

306.00

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
24.65-96.94
PE
-
EPS
-
Beta Value
-0.04993418
ISIN
INE551C01028
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
-
Employee Count
-
Website
http://www.shukrapharmaceuticals.com
Ipo Date
1998-12-30
Details
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.